A Study to Evaluate Efficacy and Safety of Daprodustat Compared to Darbepoetin Alfa in Japanese Hemodialysis (HD)-Dependent Subjects With Anemia Associated With Chronic Kidney Disease (CKD)
Condition: Anaemia Interventions: Drug: Daprodustat small; Drug: Daprodustat small placebo; Drug: Daprodustat large; Drug: Daprodustat large placebo; Drug: Darbepoetin alfa; Drug: Darbepoetin alfa placebo Sponsor: GlaxoSmithKline Recruiting - verified November 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 17, 2016 Category: Research Source Type: clinical trials
A Study to Evaluate Efficacy and Safety of Daprodustat Compared to Darbepoetin Alfa in Japanese Hemodialysis (HD)-Dependent Subjects With Anemia Associated With Chronic Kidney Disease (CKD)
Condition: Anaemia Interventions: Drug: Daprodustat small; Drug: Daprodustat small placebo; Drug: Daprodustat large; Drug: Daprodustat large placebo; Drug: Darbepoetin alfa; Drug: Darbepoetin alfa placebo Sponsor: GlaxoSmithKline Recruiting - verified December 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 17, 2016 Category: Research Source Type: clinical trials
A Study to Evaluate Efficacy and Safety of Daprodustat Compared to Darbepoetin Alfa in Japanese Hemodialysis (HD)-Dependent Subjects With Anemia Associated With Chronic Kidney Disease (CKD)
Condition: Anaemia Interventions: Drug: Daprodustat small; Drug: Daprodustat small placebo; Drug: Daprodustat large; Drug: Daprodustat large placebo; Drug: Darbepoetin alfa; Drug: Darbepoetin alfa placebo Sponsor: GlaxoSmithKline Recruiting - verified November 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 17, 2016 Category: Research Source Type: clinical trials
Observational Study of Correction of Anaemia With Darbepoetin Alfa at QM Dosing Interval in Patients With CKD Not on Dialysis
Conditions: Anaemia; Chronic Kidney Disease (CKD)Intervention: Sponsor: AmgenRecruiting - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 9, 2014 Category: Research Source Type: clinical trials
Study of Haemodialysis Patients Switching From Aranesp to Biosimilar
Condition: AnaemiaIntervention: Sponsor: AmgenRecruiting - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 7, 2014 Category: Research Source Type: clinical trials
Study of Haemodialysis Patients Switching From Aranesp to Biosimilar
Condition: AnaemiaIntervention: Sponsor: AmgenRecruiting - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 7, 2014 Category: Research Source Type: clinical trials
Study of Haemodialysis Patients Switching From Aranesp to Biosimilar
Condition: AnaemiaIntervention: Sponsor: AmgenRecruiting - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 7, 2014 Category: Research Source Type: clinical trials
Observational Study of Correction of Anaemia With Darbepoetin Alfa at QM Dosing Interval in Patients With CKD Not on Dialysis
Conditions: Anaemia; Chronic Kidney Disease (CKD)Intervention: Sponsor: AmgenActive, not recruiting - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 26, 2014 Category: Research Source Type: clinical trials
